Literature DB >> 18674395

Major depression prevalence is very high, but the syndrome is a poor proxy for community populations' clinical treatment needs.

Scott B Patten1.   

Abstract

OBJECTIVES: Some basic questions about the epidemiology of major depression (MD) remain open to debate and interpretation. Prevalence is a case in point. There have been claims that prevalence has been both over- and underestimated. This review is an attempt to reconcile this apparent contradiction.
METHOD: A literature search was carried out using MEDLINE. Articles were screened for relevance in 2 stages and bibliographies were examined to identify additional relevant publications.
RESULTS: The claim that prevalence has been overestimated appears to hinge on a concern that current diagnostic criteria fail to adequately differentiate between pathological and nonpathological mood disturbances. These arguments pertain to the validity of diagnostic criteria rather than to the prevalence of the syndrome that the criteria define. Conversely, the claim that prevalence has been underestimated is based on studies providing evidence of recall bias. If DSM-IV criteria are accepted as a diagnostic definition, MD prevalence is considerably higher than usually cited figures. However, the same literature indicates that the spectrum of severity is much broader than is usually acknowledged. The DSM-IV criteria appear to be a poor proxy for treatment need in community populations.
CONCLUSIONS: Increasing evidence suggests that MD is very common but also that DSM-IV and ICD-10 definitions capture such a broad spectrum of morbidity that they should not be regarded as de facto indicators of need, at least not in community populations.

Entities:  

Mesh:

Year:  2008        PMID: 18674395     DOI: 10.1177/070674370805300702

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  9 in total

1.  Indicators for measuring mental health: towards better surveillance.

Authors:  Cara Tannenbaum; Joel Lexchin; Robyn Tamblyn; Sarah Romans
Journal:  Healthc Policy       Date:  2009-11

2.  Demographic and clinical characteristics of consistent and inconsistent longitudinal reporters of lifetime suicide attempts in adolescence through young adulthood.

Authors:  Shelley R Hart; Rashelle J Musci; Nicholas Ialongo; Elizabeth D Ballard; Holly C Wilcox
Journal:  Depress Anxiety       Date:  2013-06-26       Impact factor: 6.505

3.  Depression and painful conditions: patterns of association with health status and health utility ratings in the general population.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Andrew G M Bulloch; Gillian Currie; Herb Emery
Journal:  Qual Life Res       Date:  2013-06-07       Impact factor: 4.147

4.  Major Depression Prevalence Increases with Latitude in Canada.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Jian Li Wang; Andrew G M Bulloch
Journal:  Can J Psychiatry       Date:  2016-10-13       Impact factor: 4.356

5.  Sustainable effects on suicidality were found for the Nuremberg alliance against depression.

Authors:  Ulrich Hegerl; Roland Mergl; Inga Havers; Armin Schmidtke; Hartmut Lehfeld; Günter Niklewski; David Althaus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-17       Impact factor: 5.270

Review 6.  The mistreatment of major depressive disorder.

Authors:  Joel Paris
Journal:  Can J Psychiatry       Date:  2014-03       Impact factor: 4.356

7.  Depressive Symptoms in Adolescents.

Authors:  Lutz Wartberg; Levente Kriston; Rainer Thomasius
Journal:  Dtsch Arztebl Int       Date:  2018-08-20       Impact factor: 5.594

8.  Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress.

Authors:  Chunye Wang; Jianyou Guo; Rongjuan Guo
Journal:  BMC Complement Altern Med       Date:  2017-01-24       Impact factor: 3.659

9.  Major depression epidemiology from a diathesis-stress conceptualization.

Authors:  Scott B Patten
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.